申请人:Chemgenesis Incorporated
公开号:US20140194536A1
公开(公告)日:2014-07-10
The present invention relates to a liquid crystal compound that can be used as a base for injection formulations. The present invention provides an amphipathic compound having the following general formula (I):
wherein X and Y each denotes a hydrogen atom or together denote an oxygen atom, n denotes an integer from 0 to 2, m denotes the integer 1 or 2, and R denotes a hydrophilic group generated by removal of one hydroxyl group from any one selected from the group consisting of glycerol, erythritol, pentaerythritol, diglycerol, triglycerol, xylose, sorbitol, ascorbic acid, glucose, galactose, mannose, dipentaerythritol, maltose, mannitol, and xylitol; as well as a base for injection formulations and depot formulation comprising the same.
本发明涉及一种可用作注射剂配方基础的液晶化合物。本发明提供了一种具有以下一般式(I)的两性化合物:其中X和Y分别表示氢原子或一起表示氧原子,n表示0至2的整数,m表示1或2的整数,R表示通过从
甘油、赤藓糖醇、五羟基
甘油、二甘
油醇、三甘
油醇、
木糖、
山梨醇、
抗坏血酸、
葡萄糖、半
乳糖、
甘露糖、二戊四醇、
麦芽糖、
甘露醇和
木糖醇中的任一种中去除一个羟基所产生的亲
水基团;以及包含该化合物的注射剂配方和缓释剂配方。